Amy Marie Wilkinson
Known title: DirectorCIK: 0001941582
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Hut 8 Secures $1.07B Credit Facility for AI Data Centers. Hut 8 closed a $1.07 billion secured credit facility to fund its expansion into AI data centers. Despite this significant financing, the stock experienced a decline, partly attributed to a director selling $2 million in shares. The company is pivoting from Bitcoin mining to AI infrastructure, a move that analysts view as a key driver for its future value.
Transaction History
| VATE | ▲ Buy | Grant | 12,016 | $0 | 8/11/2026 | View on chart |
| HUT | ▲ Buy | Option Exercise | 15,713 | — | 6/11/2026 | View on chart |
| HUT | ▼ Sell | Open Market | 20,000 | $2.0M | 5/21/2026 | View on chart |
| HUT | ▲ Buy | Option Exercise | 18,698 | — | 6/18/2025 | View on chart |
| VATE | ▲ Buy | Grant | 16,363 | $0 | 6/12/2025 | View on chart |
| HUT | ▲ Buy | Option Exercise | 245,805 | $96K | 3/28/2025 | View on chart |
| HUT | ▲ Buy | Option Exercise | 17,633 | — | 6/21/2024 | View on chart |
| VATE | ▲ Buy | Grant | 161,001 | $0 | 6/18/2024 | View on chart |
| VATE | ▲ Buy | Grant | 46,392 | $0 | 6/15/2023 | View on chart |
| VATE | ▲ Buy | Grant | 98,013 | $0 | 11/4/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Innovate Corp. highlighted in Zacks analyst blog
Innovate Corp. (VATE) was included in a recent Zacks analyst blog that also featured AMD, Linde and Amgen. The mention places the company among a group of well‑known peers, potentially drawing investor attention. The stock currently carries a dividend yield of 9.62% and trades within a 52‑week range of $3.75 to $21.30.
Innovate Corp. highlighted in Zacks analyst blog. Innovate Corp. (VATE) was included in a recent Zacks analyst blog that also featured AMD, Linde and Amgen. The mention places the company among a group of well‑known peers, potentially drawing investor attention. The stock currently carries a dividend yield of 9.62% and trades within a 52‑week range of $3.75 to $21.30.